These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1360509)

  • 1. Cardiovascular effects of LAS 30538, a new vascular selective Ca(2+)-channel blocker.
    Cardelús I; Bou J; Llenas J; Berga P; Gristwood RW
    J Pharm Pharmacol; 1992 Oct; 44(10):830-5. PubMed ID: 1360509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calcium channel blocker LAS 30538, unlike nifedipine, verapamil, diltiazem or flunarizine, potently inhibits insulin secretion in-vivo in rats and dogs.
    Gristwood RW; Furman BL; Llenas J; Jauregui J; Berga P
    J Pharm Pharmacol; 1992 Oct; 44(10):851-5. PubMed ID: 1360513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
    Barrett RJ; Appell KC; Kilpatrick BF; Proakis AG; Nolan JC; Walsh DA
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):41-53. PubMed ID: 1708055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro calcium antagonistic and antioxidant effects of Org 13061 and its enantiomers, new potential antiatherosclerotic compounds.
    Beaughard M; Chevalier A; Dureng G; Leboeuf J; Massingham R; Mazur A; Rayssiguier Y; Winslow E
    Fundam Clin Pharmacol; 1997; 11(5):416-26. PubMed ID: 9342595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
    Nakayama N; Ikezono K; Mori T; Yamashita S; Nakayama S; Tanaka Y; Hosokawa T; Minami Y; Masutani K; Yamamura Y
    J Cardiovasc Pharmacol; 1990 May; 15(5):836-44. PubMed ID: 1692946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium blocking properties of piprofurol.
    Pourrias B; Huerta F; Santamaria R; Bowe C
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):223-39. PubMed ID: 4026458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.
    Petty MA; Mir AK
    Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
    Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ
    Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
    Iwamoto T; Nishimura N; Morita T; Sukamoto T
    J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of R 56865 and calcium entry blockers on K+- and noradrenaline-induced contractions and 45Ca uptake in rat aorta.
    Koch P; Wilhelm D; Wermelskirchen D; Nebel U; Wilffert B; Peters T
    Eur J Pharmacol; 1988 Dec; 158(3):183-90. PubMed ID: 3253097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of a novel 1,5-benzothiazepine calcium antagonist.
    Shiga H; Miyake S; Ideka M; Ito Y; Yanagisawa H; Koike H
    Arzneimittelforschung; 1992 May; 42(5):617-21. PubMed ID: 1530673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of bepridil and diltiazem on systemic blood pressure and isolated peripheral arteries in spontaneously hypertensive rats.
    Fujimoto S; Aoki K; Matsuda T
    Eur J Pharmacol; 1986 May; 124(3):243-54. PubMed ID: 3488222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
    Angus JA; Brazenor RM; Le Duc MA
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
    Dong H; Sheng JZ; Lee CM; Wong TM
    Br J Pharmacol; 1993 May; 109(1):113-9. PubMed ID: 8495235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
    Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
    Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.